author-photo

Ubaldo Occhini

6

Papers

152

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Minimal Residual Disease (MRD) at 10-6 Measured By Next Generation Flow (NGF) during Daratumumab Consolidation Therapy: Analysis at 18 Months Follow up of DART4MM Study (Daratumumab Treatment For Multiple Myeloma Eradication)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
phase 1/2 study in patients with myelofibrosis Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a

2012
Show All
- Source
- Cite
- Save
Citations (0)
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib

2011 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (27)
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis

2011 Blood
Show All
- Source
- Cite
- Save
Citations (125)